Trounson navigated tricky political waters, given the makeup of CIRM’s board. For most of his tenure, the board was led by Bob Klein, the hard-charging head of the ballot measure that carved out the semi-autonomous agency, and over the past two years has worked with Jon Thomas.

At the same time, critics complained of Trounson’s travels, including trips to Europe and other locales to line up scientific alliances between CIRM and other nations, and perceived conflicts of interest in CIRM’s grant-making process.

“He has helped establish us as a world leader in the field of stem cell research,” Thomas said in the CIRM press release. “We are truly grateful for his vision, his expertise and his leadership. He has created a legacy which he can be proud of.”

Related links:

Industries:

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.